15
Participants
Start Date
March 9, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Rituximab
Rituximab weekly until B%\<0.5% or B#\<20×10\^6/L
Belimumab
Belimumab every four weeks
RECRUITING
Peking Union Medical College Hospital, Beijing
Children's Hospital of Chongqing Medical University
OTHER
Central South University
OTHER
Shenzhen Children's Hospital
OTHER_GOV
The First Hospital of Jilin University
OTHER
Children's Hospital of The Capital Institute of Pediatrics
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Children's Hospital of Nanjing Medical University
OTHER
Children's Hospital of Fudan University
OTHER
Shengjing Hospital
OTHER
Shanghai Children's Hospital
OTHER
Tianjin Children's Hospital
OTHER
Peking Union Medical College Hospital
OTHER